Prespecified falsification end points: Can they validate true observational associations?

JAMA

Volumn 309, Issue 3, 2013, Pages 241-242

  Prasad, Vinay ^a   Jena, Anupam B ^b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BISPHOSPHONIC ACID DERIVATIVE; CLOPIDOGREL; PROTON PUMP INHIBITOR;

ADVERSE OUTCOME; CLINICAL EFFECTIVENESS; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMUR FRACTURE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HIP FRACTURE; HUMAN; OBSERVATIONAL STUDY; OSTEOARTHRITIS; PATIENT COMPLIANCE; PNEUMONIA; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRIORITY JOURNAL; RARE DISEASE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEIZURE; SHORT SURVEY; SIDE EFFECT; SUDDEN DEATH; THORAX PAIN; URINARY TRACT INFECTION; VALIDATION PROCESS; ARTICLE; BIOASSAY; DRUG TOXICITY; EPIDEMIOLOGY; FRAUD; METHODOLOGY; OBSERVATION; OBSERVER VARIATION; SAMPLE SIZE;

CAUSALITY; DRUG TOXICITY; ENDPOINT DETERMINATION; FRAUD; OBSERVATION; OBSERVER VARIATION; PRODUCT SURVEILLANCE, POSTMARKETING; RESEARCH DESIGN; SAMPLE SIZE;

MLCS; MLOWN;

EID: 84872387536     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.96867     Document Type: Short Survey

References (8)

1. Thomas L, Peterson ED. The value of statistical analysis plans in observational research: defining high-quality research from the start. JAMA. 2012;308(8):773-774.
2. Ioannidis JP. The importance of potential studies that have not existed and registration of observational data sets. JAMA. 2012;308(6):575-576.
3. Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366(20):1881-1890.
4. Jena AB, Sun E, Goldman DP. Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia [published online September 7, 2012]. J Gen Intern Med. doi:10.1007/s11606-012-2211-5.
5. Park-Wyllie LY, Mamdani MM, Juurlink DN, et al. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA. 2011; 305(8):783-789.
6. Black DM, Kelly MP, Genant HK, et al; Fracture Intervention Trial Steering Committee; HORIZON Pivotal Fracture Trial Steering Committee. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl JMed. 2010;362(19):1761-1771.
7. Bertrand M, Duflo E, Mullainathan S. How much should we trust differencesin-differences estimates? Q J Econ. 2004;119:249-275.
8. Cohen-Cole E, Fletcher JM. Detecting implausible social network effects in acne, height, and headaches: longitudinal analysis. BMJ. 2008;337:a2533.